fda glp-1 compounding enforcement news october 2025 Congress Introduces SAFE Drugs Act of 2025, Expanding Oversight of Compounded Drugs and Telehealth Providers FDA Narrows Compounding Rules for

This is my number one go-to nutrient

So this is now looking at a much larger database and looking at two drugs, they're looking at a drug called Sexenda (liraglutide), which is a much older drug than Ozempic or semaglutide, and they are looking at semaglutide

Register for access to our free webcast: ...or contact us: #pharma #deviceregulatory #riskmanagement #combinationproduct #drugdelivery #FDA #regulatoryaffairs Max Lerman, PhD Sarah Mollo Rob Schulz BlueRidge Life Sciences To view or add a comment, sign in The FDA has taken a step toward greater transparency and efficiency in drug development by publishing the internal filing checklists used by CDER reviewers

ukawski et al

Absorption of other medications can be impacted due to intestinal bypass

Lau W, Kato H, Nosaka K